|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-7-24
|
|
pubmed:abstractText |
Cardiovascular disease is the dominant cause of death in renal transplant recipients. Left ventricular hypertrophy (LVH) is a known risk factor. After renal transplantation, persistent hypertension is an important determinant for the further evolution of LVH. The aim of the present study was to compare the effect of an angiotensin converting enzyme (ACE) inhibitor (lisinopril) with a calcium channel blocker (CCB) (controlled release nifedipine) in treatment of posttransplant hypertension focusing on changes in LVH.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
107-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11468543-Adult,
pubmed-meshheading:11468543-Antihypertensive Agents,
pubmed-meshheading:11468543-Calcium Channel Blockers,
pubmed-meshheading:11468543-Cyclosporine,
pubmed-meshheading:11468543-Delayed-Action Preparations,
pubmed-meshheading:11468543-Double-Blind Method,
pubmed-meshheading:11468543-Echocardiography,
pubmed-meshheading:11468543-Female,
pubmed-meshheading:11468543-Heart,
pubmed-meshheading:11468543-Heart Ventricles,
pubmed-meshheading:11468543-Humans,
pubmed-meshheading:11468543-Hypertension,
pubmed-meshheading:11468543-Immunosuppressive Agents,
pubmed-meshheading:11468543-Kidney Transplantation,
pubmed-meshheading:11468543-Lisinopril,
pubmed-meshheading:11468543-Male,
pubmed-meshheading:11468543-Middle Aged,
pubmed-meshheading:11468543-Nifedipine,
pubmed-meshheading:11468543-Prospective Studies,
pubmed-meshheading:11468543-Time Factors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
|
|
pubmed:affiliation |
Department of Nephrology, National Hospital, University of Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
